| Financial Year |
March 31 2023 |
| Monetary Funds |
1,884,192,503.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
170,420,240.58 |
| Advances to Suppliers |
43,864,514.70 |
| Other Receivables |
22,205,942.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
50,069,440.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
236,053,360.73 |
| Total Current Assets |
2,406,806,001.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,137,445.14 |
| Investment Properties |
621,999.32 |
| Fixed Assetes |
4,256,871,065.22 |
| Under-construction Projects |
952,543,273.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
377,571,505.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,912,957.74 |
| Deferred Income Tax Assets |
75,760,965.63 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,711,805,353.86 |
| Total Assets |
8,118,611,355.85 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
326,930,714.40 |
| Accounts Received In Advance |
62,858.35 |
| Employee Compensation Payable |
170,270,481.27 |
| Taxes Payable |
113,767,423.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
119,567,546.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,747,331.70 |
| Other Current Liabilities |
646,695.23 |
| Sub-Total of Current Liabilities |
763,244,395.78 |
| Long-term Loans |
431,815,916.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,827,936.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
31,103,481.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
639,138,382.46 |
| Total Liabilities |
1,402,382,778.24 |
| Paid-In Capital(Or Share Stock) |
2,228,933,187.00 |
| Capital Surplus |
297,648,078.58 |
| Surplus Reserve |
261,608,331.96 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,301,953,433.61 |
| Minority Stockholder's Interest |
2,619,967,308.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,096,261,268.99 |
| Owner's Equity（Stockholder's Equity） |
6,716,228,577.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,118,611,355.85 |
